Acrospire Investment Management LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 45 filers reported holding PSYCHEMEDICS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q2 2017$65,000
-27.0%
2,612
-41.4%
0.06%
-17.6%
Q1 2017$89,000
-52.2%
4,460
-40.7%
0.07%
-3.9%
Q4 2016$186,000
+708.7%
7,526
+535.6%
0.08%
+413.3%
Q3 2016$23,0001,1840.02%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders